Liver fibrosis is the process where healthy liver tissue is gradually replaced by scar tissue due to chronic injury. Causes include viral hepatitis, alcohol use, fatty liver disease, and certain medications. Over time, fibrosis can impair liver function and lead to cirrhosis, a serious condition. Early stages often have no symptoms, so noninvasive tools like the FIB-4 index help estimate fibrosis risk using routine blood tests and age.
The FIB-4 index combines four parameters: age, aspartate aminotransferase (AST), alanine aminotransferase (ALT), and platelet count. The formula is:
Where:
Higher age and AST increase the score, while higher platelets and ALT reduce it. This balance helps differentiate between temporary enzyme elevations and chronic liver scarring.
The FIB-4 score estimates the likelihood of significant liver fibrosis. Interpretation depends on age-adjusted cutoff values:
| Age Group | FIB-4 Score Range | Fibrosis Risk Category |
|---|---|---|
| Under 65 years | < 1.45 | Low risk |
| Under 65 years | 1.45 โ 3.25 | Indeterminate risk |
| Under 65 years | > 3.25 | High risk |
| 65 years and older | < 2.0 | Low risk |
| 65 years and older | 2.0 โ 2.67 | Indeterminate risk |
| 65 years and older | > 2.67 | High risk |
A low score suggests a low likelihood of advanced fibrosis, but does not guarantee absence of liver disease. Indeterminate scores indicate the need for further testing, such as elastography or specialist evaluation. High scores suggest a higher probability of advanced fibrosis or cirrhosis and warrant prompt medical attention.
Consider a 40-year-old patient with the following lab values:
Calculate the FIB-4 score:
Since the patient is under 65, the cutoff for high risk is >3.25 and low risk is <1.45. A score of 2.9 falls in the indeterminate range, suggesting further evaluation is needed.
AST and ALT are enzymes released when liver cells are injured. AST can also rise from muscle injury or other conditions, so it is not specific to the liver. ALT is more liver focused, which is why the formula uses the square root of ALT to temper the impact of short-term spikes. Platelet count tends to drop as liver scarring advances, so lower platelets increase the score and suggest more chronic disease.
Age is included because fibrosis risk increases with time and because age affects the predictive value of the same lab numbers. The age adjustment helps reduce false positives in older adults who naturally have higher baseline risk. It also reminds patients that lab values should be interpreted over time, not in isolation.
The FIB-4 score is best used as a screening tool. A low score can help rule out advanced fibrosis in many patients, which can reduce the need for invasive testing. An indeterminate score means the calculator alone is not enough, and clinicians may recommend additional noninvasive tests such as elastography or other blood-based indices. A high score increases concern for significant fibrosis, but it still needs clinical confirmation.
If your score is near the cutoff, consider repeating labs or confirming with your provider before making conclusions. Consistent trends across multiple tests are more informative than a single outlier. Use the calculator to track changes over time rather than as a one-time verdict.
Different labs may report slightly different reference ranges. If your tests come from different facilities, ask your clinician whether the values are comparable before concluding that your score has changed.
This table shows how the same lab values can fall into different risk categories depending on age.
| Age | FIB-4 score | Risk category |
|---|---|---|
| 50 | 1.8 | Indeterminate |
| 50 | 3.4 | High |
| 70 | 1.8 | Low |
| 70 | 2.6 | Indeterminate |
If your score is low, your clinician may recommend routine monitoring rather than immediate imaging. If your score is indeterminate or high, additional tests can refine the risk assessment. This might include transient elastography, other blood-based indices, or referral to a specialist. The goal is to combine multiple signals before making treatment decisions.
Repeat testing is most useful when it is paired with a consistent lab environment and similar health conditions. If you have an acute infection, injury, or medication change, consider waiting until you are stable before retesting. A stable downward trend is more reassuring than a single low result.
Weight management, reduced alcohol intake, and control of metabolic conditions like diabetes can improve liver health. Some patients see improved enzymes and lower FIB-4 scores after sustained lifestyle changes. Medication adherence for viral hepatitis or other chronic conditions also plays a major role. The calculator can help you see how those changes affect your score over time.
If you are in a monitoring program, keep copies of lab reports and note any medication changes between tests. This context helps your care team interpret why a score changed. The FIB-4 value alone does not explain the cause of injury, so clinical history still matters.
Consistent monitoring improves decision-making.
Discuss any changes with your clinician.
This tool provides an estimate and should not replace professional medical advice. Always discuss results with a healthcare provider.
Enter age in years, AST and ALT in units per liter (U/L), and platelet count in 109 per liter as reported on your lab report.
Frequency depends on your clinical situation. For ongoing liver conditions, periodic monitoring every 6โ12 months may be recommended by your provider.
A high score suggests possible advanced fibrosis. Consult a healthcare professional for further evaluation and management.
Yes. Managing risk factors like alcohol intake, weight, and metabolic health can improve liver function and potentially lower fibrosis risk over time.
Normal aging can increase the FIB-4 score independently of fibrosis. Age-adjusted cutoffs help reduce false positives in people over 65.
The FIB-4 Liver Fibrosis Calculator is a practical tool to estimate liver fibrosis risk using common lab values and age. It helps identify individuals who may need further testing or specialist referral. Understanding the formula, interpretation, and limitations ensures better use of this calculator as part of comprehensive liver health assessment.